Ischemic colitis causes: Difference between revisions
Line 11: | Line 11: | ||
===Non-occlusive Ischemia=== | ===Non-occlusive Ischemia=== | ||
* In hemodynamically unstable patients (i.e. [[shock]] patients) the [[mesenteric]] perfusion may be compromised. | * In hemodynamically unstable patients (i.e. [[shock]] patients) the [[mesenteric]] perfusion may be compromised. | ||
* [[Low blood pressure]] | |||
===Occlusive Ischemia=== | ===Occlusive Ischemia=== | ||
*Obstructive atherosclerotic disease | *Obstructive atherosclerotic disease | ||
:*[[Superior mesenteric artery]] occlusion | :*[[Superior mesenteric artery]] occlusion |
Revision as of 13:35, 22 March 2017
Ischemic colitis Microchapters |
Case Studies |
Ischemic colitis causes On the Web |
American Roentgen Ray Society Images of Ischemic colitis causes |
Risk calculators and risk factors for Ischemic colitis causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Causes of the reduced blood flow can include changes in the systemic circulation (e.g. low blood pressure) or local factors such as constriction of blood vessels or a blood clot. In most cases, no specific cause can be identified.[1]
Causes
Ischemic colitis is often classified according to the underlying cause. Non-occlusive ischemia develops because of low blood pressure or constriction of the vessels supplying blood to the colon; occlusive ischemia indicates that a blood clot or other blockage has cut off blood flow to the colon. In most cases, no specific cause can be identified.
Non-occlusive Ischemia
- In hemodynamically unstable patients (i.e. shock patients) the mesenteric perfusion may be compromised.
- Low blood pressure
Occlusive Ischemia
- Obstructive atherosclerotic disease
- Superior mesenteric artery occlusion
- Most commonly the embolism is due to atrial fibrillation
- Valvular heart disease including endocarditis
- Myocardial infarction
- Cardiomyopathy
Drugs
- Alosetron
- Cilansetron
- Interferon alfacon-1
- Pegylated interferon alfa-2b
- Ramosetron
- Vasopressors
- Ergotamine
References
- ↑ Feldman: Sleisenger & Fordtran's Gastrointestinal and Liver Disease, 7th ed., 2002 Saunders, p. 2332.